AKYA Akoya BioSciences Inc

Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced that Company management will be participating in three upcoming investor conferences.

• Stephens Annual Investment Conference | NASH 2023Fireside Chat on Wednesday, November 15th at 11:00 AM CTNashville, TN

• Canaccord Genuity 2023 MedTech, Diagnostics and Digital Health & Services ForumFireside Chat on Thursday, November 16th at 2:30 PM ETNew York, NY

• Piper Sandler 35th Annual Healthcare ConferenceFireside Chat on Thursday, November 30th at 11:30 AM ET        New York, NY

A live and archived webcast of the events will be available on the “Investors” section of the Akoya website at https://investors.akoyabio.com/.

About Akoya BiosciencesAs The Spatial Biology Company®, Akoya Biosciences’ mission is to bring context to the world of biology and human health through the power of spatial phenotyping. The company offers comprehensive single-cell imaging solutions that allow researchers to phenotype cells with spatial context and visualize how they organize and interact to influence disease progression and response to therapy. Akoya offers a full continuum of spatial phenotyping solutions to serve the diverse needs of researchers across discovery, translational and clinical research via its key platforms: PhenoCycler™, PhenoImager™ Fusion and PhenoImager HT. To learn more about Akoya, visit www.akoyabio.com.

Investor Contact:Priyam ShahSr. Director, Investor RelationsAkoya Biosciences, Inc.investors@akoyabio.com

Media Contact:Christine Quern(617) 650-8497media@akoyabio.com